U.S. Markets closed

Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Quest Diagnostics Incorporated (NYSE: DGX) and Encourages Quest Diagnostics Investors to Contact the Firm

NEW YORK, June 09, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (DGX).

Click here to participate in the action.

On June 3, 2019, the Company disclosed that it had been notified by a billing services vendor that, between August 1, 2018 and March 30, 2019, an unauthorized user had gained access to data for nearly 11.9 million patients, including credit card numbers and bank account information.

If you are a long term stockholder of Quest Diagnostics, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information concerning our investigation into Quest Diagnostics, please go to https://bespc.com/dgx/.  For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com.  Attorney advertising.  Prior results do not guarantee similar outcomes. 

Contacts
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com